Innovator and inventor Leen Kawas is the managing general partner of Propel Bio Partners, a life science investment firm that drives its strategy with science and business expertise Leen Kawas Opinions expressed by Entrepreneur contributors are their own. You’re reading Entrepreneur India, an international franchise of Entrepreneur Media. Life science companies that are working on therapeutics and technologies to treat diseases and improve our quality of life require significant innovation, talent, and upfront investment. From drug discovery to clinical testing and eventually regulatory approval and commercialization, it can take years before a product generates revenue. In today’s market with a downward economic trend, one industry leader says the sector presents a unique opportunity for growth. if they invest in the right technology and team. "It is a classical secular-growth sector," Kawas commented. "There are several factors that will continue to impact the sector positively, aging population, heightened awareness and wealth effect is increasing healthcare spending, climbing obesity and metabolic disorders, this is just to list a few". Kawas added. Innovator and inventor Leen Kawas is the managing general partner of Propel Bio Partners, a life science investment firm that drives its strategy with science and business expertise. In that […]
Click here to view original web page at www.entrepreneur.com
